Hangzhou Tiger Pharmaceutical Holdings Co. - Unsponsored ADR (HNGZY)

Overview

Hangzhou Tigermed Consulting Co., Ltd is a prominent contract research organization that offers a comprehensive range of services for preclinical and clinical development to clients both within the People’s Republic of China and globally. Since its inception in 2004, the company has been headquartered in Hangzhou, showcasing a dedication to providing innovative solutions in the pharmaceutical, biotechnology, and medical device sectors. With operations spanning across various segments, including Clinical Trial Solutions, and Clinical-related and Laboratory Services, Tigermed has established itself as a key player in aiding companies navigate through the complexities of drug and medical product development and regulatory compliance.

Products and Services

Preclinical Development Services: These services encompass a range of studies necessary for progressing a medical product from the concept phase towards clinical trials. This includes medicinal chemistry for drug design and synthesis, compound screening for efficacy and selectivity, Drug Metabolism and Pharmacokinetics (DMPK) studies, safety and toxicology assessments, bioanalytical testing for analyzing compounds in biological matrices, and formulation research and development for determining the most effective delivery methods.

Clinical Development Services: Tigermed provides comprehensive support for all phases of clinical trials, including medical writing to prepare necessary documentation, clinical monitoring to ensure trials run smoothly, regulatory affairs to navigate the legal and ethical frameworks, data management and statistical analysis for interpreting trial results, clinical development strategy to optimize the trial processes, site management to oversee trial locations, subject recruitment for ensuring adequate and suitable participants, and specialized services for medical devices/in vitro diagnostics, multi-region clinical trials, and vaccine clinical trials.

Market and Registration Strategy Services: A full suite of services to support products from market research and marketing strategy development, through to the product finalization and verification stages. Tigermed offers registration strategy planning, marketing application assistance, post-marketing support, and product upgrade advice to ensure successful market entry and sustained market presence.

Additional Support Services: Tigermed extends its support beyond the typical boundaries of clinical research to offer medical imaging, pharmacovigilance for monitoring the safety of pharmaceuticals post-launch, medical translation for diverse regulatory environments, quality assurance, GMP (Good Manufacturing Practice) consulting, central laboratories for complex analyses, functional services outsourcing, EDC (Electronic Data Capture) systems for data acquisition, and call center services for trial and product support.

Post-marketing Clinical Research Solutions: Focused on the period after a product is launched, these services include site identification and selection for further studies, central monitoring to oversee ongoing research, project team management, vendor management for coordinating with other service providers, and comprehensive project management to ensure the success of post-marketing strategies.